Health Care & Life Sciences » Pharmaceuticals | Auris Medical Holding AG

Auris Medical Holding AG | Mutual Funds

Mutual Funds that own Auris Medical Holding AG

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
ZKB Fonds Aktien Gesundheit
111,838
0.47%
28
0.06%
05/31/2018
Adamant Global Generika
57,500
0.24%
0
0.02%
12/29/2017
Tekla Healthcare Investors
54,215
0.23%
0
0%
12/31/2017
Adamant Global Biotech
41,875
0.17%
0
0.01%
12/29/2017
Adamant Global Medtech
23,838
0.1%
0
0%
12/29/2017
Fidelity Nasdaq Composite Index
18,206
0.08%
0
0%
07/31/2018
Herculis Partners Aries Fund
6,000
0.03%
0
0.03%
07/31/2018
ZKB IF Aktien Ausland aktiv
914
0%
-13
0%
07/31/2018
Tekla Life Sciences Investors
0
0%
-23,235
0%
12/31/2017

About Auris Medical Holding

View Profile
Address
Clarendon House
Hamilton HC HM 11
Bermuda
Employees -
Website http://www.aurismedical.com
Updated 07/08/2019
Auris Medical Holding AG engages in the provision of biopharmaceutical business. It focuses on the development of novel products for the treatment of inner ear disorders. It includes tinnitus, haring loss, and meniere's disease.